The multikinase inhibitor Sorafenib enhances glycolysis and synergizes with glycolysis blockade for cancer cell killing.
about
Modulation of Autophagy by Sorafenib: Effects on Treatment ResponseThe Warburg effect and drug resistanceReactive Oxygen Species-Mediated Mechanisms of Action of Targeted Cancer TherapySynergistic effects of ascorbate and sorafenib in hepatocellular carcinoma: New insights into ascorbate cytotoxicity.NUPR1, a new target in liver cancer: implication in controlling cell growth, migration, invasion and sorafenib resistance.Sorafenib-induced defective autophagy promotes cell death by necroptosis.Metabolic reprogramming of the tumour microenvironment.Chemotherapeutic xCT inhibitors sorafenib and erastin unraveled with the synaptic optogenetic function analysis toolInduction of ROS Overload by Alantolactone Prompts Oxidative DNA Damage and Apoptosis in Colorectal Cancer CellsCrocetin shifts autophagic cell survival to death of breast cancer cells in chemotherapy.Quantitative analysis of autophagic flux by confocal pH-imaging of autophagic intermediatesTargeting glucosylceramide synthase upregulation reverts sorafenib resistance in experimental hepatocellular carcinoma.Sorafenib and 2-Deoxyglucose Synergistically Inhibit Proliferation of Both Sorafenib-Sensitive and -Resistant HCC Cells by Inhibiting ATP Production.Reduced production and uptake of lactate are essential for the ability of WNT5A signaling to inhibit breast cancer cell migration and invasion.Fasting inhibits hepatic stellate cells activation and potentiates anti-cancer activity of Sorafenib in hepatocellular cancer cells.Association of liver cirrhosis severity with type 2 diabetes mellitus in hepatocellular carcinoma.The relevance of tyrosine kinase inhibitors for global metabolic pathways in cancer.Combined Metabolic Targeting With Metformin and the NSAIDs Diflunisal and Diclofenac Induces Apoptosis in Acute Myeloid Leukemia Cells
P2860
Q26745320-AB8746F0-935E-4CE4-9803-6BBED628B325Q26770007-4F3D5F9B-1FAB-48F2-B182-552335DE63D7Q33862425-9DFD4B52-E8DA-4CA6-9BC4-733924B9A06FQ36901967-D158759B-9E14-4D6C-A585-82BC9B4D84E2Q37482829-58587B45-9D5A-4341-8B3B-89AAA23662D7Q38261907-A7A8F4B4-655B-4E70-819C-2A8EDFD99E46Q38563128-82212975-11A3-4950-9BFB-6CE7E098F348Q38611037-F686FDE4-7785-4BAD-AD04-8B0BDDB15239Q38777392-58A2D215-63DC-4EA5-9D53-A2399E3C37E0Q38870671-AAF369FC-E3CA-47CF-9534-88743567A79CQ39961482-26F88B85-07F5-4ECC-97D1-6CEDE40DAB8CQ40060996-E6084274-2256-49D9-917C-892D2B6B76B9Q42323382-C00B955B-3A3A-4AB3-B043-22E91E0BD1DBQ42699124-D301E4BE-8FC3-4F2D-81D6-96F43D18B43FQ46082155-73083754-93A7-40F9-BF9D-5D8DE470CF83Q49545298-D826901E-81E8-40C0-82E4-946EDA652BD9Q49887915-18119627-330C-45D0-B192-9113D7CD5431Q59132138-7720AF5F-179F-406D-AEA3-FC264AD155D4
P2860
The multikinase inhibitor Sorafenib enhances glycolysis and synergizes with glycolysis blockade for cancer cell killing.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
The multikinase inhibitor Sora ...... ckade for cancer cell killing.
@ast
The multikinase inhibitor Sora ...... ckade for cancer cell killing.
@en
type
label
The multikinase inhibitor Sora ...... ckade for cancer cell killing.
@ast
The multikinase inhibitor Sora ...... ckade for cancer cell killing.
@en
prefLabel
The multikinase inhibitor Sora ...... ckade for cancer cell killing.
@ast
The multikinase inhibitor Sora ...... ckade for cancer cell killing.
@en
P2093
P2860
P50
P356
P1433
P1476
The multikinase inhibitor Sora ...... ockade for cancer cell killing
@en
P2093
Alessandro Pontoglio
Anna Chiara Piscaglia
Antonio Gasbarrini
Camilla Bernardini
Daniela Samengo
Laura Castellini
Maria Ausiliatrice Puglisi
Roberto Scatena
Valentina Tesori
P2860
P2888
P356
10.1038/SREP09149
P407
P577
2015-03-17T00:00:00Z